Inscrivez-vous
Newsroom
Arjo acquires AirPal – a US company focused on patient transfers
Arjo today announces the acquisition of AirPal, a privately owned US-based company specializing in Air-Assisted Lateral Patient Transfer solutions. The deal will strengthen Arjo’s Patient Handling portfolio and is expected to have a positive impact on earnings per share from 2022 and onwards.
Arjo presents updated strategy for continued profitable growth
Arjo’s updated strategy and new financial targets for 2021-2023 will be presented today at the Group’s Capital Markets Day. With the new strategy, Arjo is taking an important step in offering outcome-based solutions for healthcare, while focusing on enhancing efficiency. The financial targets include annual organic growth of 3-5% combined with an...
Arjo interim report January-september 2020
”We add a very strong quarter to the books. We continue to deliver profitable growth and grow organically by 5.8% in the quarter, while increasing our operating profit by 67%,” says Joacim Lindoff, President and CEO. “The challenges associated with Covid-19 continues and we are handling the situation here and now while investing in our long-term...
Arjo announces date of 2020 Q3 report and conference call
Arjo will issue its Q3 report for 2020 on Wednesday October 28 at 07:00 CET, followed by a conference call at 08:00 CET, hosted by Joacim Lindoff, President & CEO, and Daniel Fäldt, CFO.
Welcome to Arjo’s Capital Markets Day on November 2, 2020
Arjo invites analysts, institutional investors and the media to the company’s Capital Markets Day on November 2, 2020, in Malmö. Due to the corona pandemic, participation will be offered via online streaming on Arjo’s website, www.arjo.com, with limited in-person participation at Arjo’s head office at Hans Michelsensgatan 10, in Malmö, Sweden. The...
Arjo strengthens Wound Care offering by acquiring equity stake in Bruin Biometrics
Today, Arjo has acquired an equity stake in Bruin Biometrics (BBI), a US-based company developing solutions for biometric diagnosis. The deal gives Arjo exclusive distribution rights for BBI’s portable SEM scanner, which allows early detection of pressure injury risk and thereby reduce patient suffering and healthcare costs. With this acquisition,...
Arjo enters into distribution agreement with BrainLit, a lighting technology company focused on improving health, welfare and productivity
Arjo has signed an exclusive distribution agreement with Brainlit, a Swedish innovative lighting technology company. BrainLit’s BioCentric Lighting™ system is an advanced, feedback-driven, self-learning system that creates natural light environments that contribute to improved health and wellbeing.
Save the date for Arjo’s Capital Markets Day 2020
Arjo invites analysts, institutional investors and the media to the company’s Capital Markets Day on November 2, 2020 at Arjo’s head office in Malmö, Sweden. Due to the current coronavirus pandemic, the number of physical participants will be limited and digital participation will be possible. More details on the Capital Markets Day will be...
Arjo interim report January-June 2020
”During the quarter, we have continued the important job of supporting healthcare through these challenging times. We grew organically by 2.2%, which should be seen in relation to a strong comparative quarter of 2019. At the same time, the adjusted operating profit (EBIT) increased by almost 50%. We have seen continued high demand within our US...
Resolutions at Arjo’s Annual General Meeting 2020
At the Annual General Meeting of Arjo AB (publ) held on 29 June 2020, the following was resolved.
Arjo announces date of 2020 Q2 report and conference call
Arjo will issue its Q2 report for 2020 on Friday July 17 at 07:00 CET, followed by a conference call at 08:00 CET, hosted by Joacim Lindoff, President & CEO, and Daniel Fäldt, CFO.
Arjo’s operating profit for the second quarter of 2020 estimated to be significantly better than expected
Arjo expects its operating profit for the second quarter of 2020 to increase by more than 30% compared to the corresponding quarter in 2019, which is significantly better than the consensus from analysts.
Rehabilitation of Covid-19 patients requires significant investments in both modern equipment and staff
The physically demanding and complex work performed by hospital staff around the world due to the corona pandemic is now transferring to follow-up care and the rehab sector, which are facing major challenges. Arjo has extensive experience of working together with healthcare to ensure the right care environment, know-how and expertise among staff,...
NOTICE OF ANNUAL GENERAL MEETING IN ARJO AB
The shareholders of Arjo AB (publ), Reg. No. 559092-8064, are hereby invited to attend the Annual General Meeting (the “AGM”) to be held on Monday 29 June 2020 at 11.00 a.m. CET, at Arjo’s headquarters at Hans Michelsensgatan 10, Malmö, Sweden.
Arjo interim report January-March 2020
”We deliver a strong start to the year with an organic growth of 3,4%. We see clear results from our efficiency measures and our operating profit increases by over 20%, while at the same time having a solid financial position. The effects from the coronapandemic becomes clear at the end of the quarter with an increased demand for hospital beds and...
Arjo announces date of 2020 Q1 report and conference call
Arjo will issue its Q1 report for 2020 on Monday April 27 at 07:00 CET, followed by a conference call at 08:00 CET, hosted by Joacim Lindoff, President & CEO, and Daniel Fäldt, CFO.
Annual Report 2019: Arjo enables mobility throughout the care process
Arjo today publishes its 2019 Annual Report, providing insights regarding the company's operations and initiatives to create value for healthcare. Continued strong growth in North America and Rest of the World, solid results from efficiency measures, and a strengthened offering, including acquisitions and partnerships, were some of the success...
Arjo postpones Annual General Meeting and Capital Markets Day
Arjo’s Board of Directors has today decided to postpone the Annual General Meeting (AGM). The decision is made as a result of the Swedish Government’s decision to ban public gatherings and events with more than 50 people as of Sunday, 29 March to reduce the spread of COVID-19. The decision is to be followed for other types of gatherings as well.
NOTICE OF ANNUAL GENERAL MEETING IN ARJO AB
The shareholders of Arjo AB (publ), Reg. No. 559092-8064, are hereby invited to attend the Annual General Meeting (the “AGM”) to be held on Monday 27 April 2020 at 11.00 a.m. CET, in Luftkastellet, Utsiktsvägen 10, Malmö, Sweden.
Welcome to Arjo’s Capital Markets Day on May 13, 2020
Arjo invites analysts, institutional investors and the media to the company’s Capital Markets Day on May 13th, 2020. The event will be held at Arjo’s head office at Hans Michelsensgatan 10, in Malmö, Sweden. The presentations will begin at 11:00 a.m. and end at about 4:30 p.m. Registration will open at 10:30 a.m.
Arjo's new CFO will take office on March 16
Arjo announced on January 17 that Daniel Fäldt has been appointed new Chief Financial Officer (CFO) and member of the Arjo AB Management Team with start during the second quarter of 2020. The starting date has now been changed to an earlier date, March 16.
Arjo initiates a randomized controlled trial for wound care treatment after strong evaluation results
Arjo will today publish the results from a highly successful multi-centre clinical evaluation for the recently launched WoundExpress™. WoundExpress is a ground breaking patented therapy for Venous Leg Ulcers (VLU). Further clinical research studies, including a pivotal randomised controlled trial, are now underway. Arjo aims to establish...
Arjo publishes year-end report January-December 2019
“We finish the year with continued growth in the quarter and begin to see the positive results from the efficiency measures in the US and the UK. Our positions are strengthened across all regions and we put another successful year behind us as the Group grows organically by nearly 4%. We deliver on all of our financial targets and raise the...
Daniel Fäldt appointed CFO at Arjo AB
Daniel Fäldt has been appointed Chief Financial Officer (CFO) and member of the Arjo AB Management Team. Daniel has extensive experience from senior positions within finance in global stock-listed organizations, and most recently as CFO of BE Group.
Arjo announces date of 2019 year-end report and conference call
Arjo will issue its year-end report for 2019 on Tuesday February 4 at 07:00 CET, followed by a conference call at 08:00 CET, hosted by Joacim Lindoff, President & CEO, and Jonas Lindqvist, CFO. The previously communicated date of February 3 has been altered for practical reasons.